After many years of basic research, regenerative medicine represents a remarkable foremost innovation in medical care. Comprising principles of stem cell technology and tissue engineering, also combining advanced biomaterials with small molecules and biologics, to replace or regenerate human tissues and organs and restore their functions, regenerative medicine approaches appears as the most valuable technological synergies.
Beyond the treatment option for acute injuries, chronic diseases and congenital malformations, regenerative medicine opens a plethora of opportunities in therapeutics, across multiple fields of research, including difficult-to-treat diseases and physically impaired tissues. Although still demanding more specialization for both scientists and clinicians, regenerative medicine is destined to address the most concerning challenges of the current medical therapies.
Significant financial support from both public and private funding sources is still needed for research and clinical innovation. Due to the impact of this technology in the healthcare sector, long-term vision and strategy are crucial to accelerate the development of novel therapies and to promote the stability of long-term established collaborations worldwide. Beyond financial and technical affairs, process development, manufacturing, and logistics, as well as, and intellectual protection concerns through patents and utility models, need to be essentially covered, for success.
This research service (RS) depicts the current landscape and the new trends in regenerative medicine, focusing on:
Technology roadmap, trends, capability, and applications targeted
Stakeholder activities, influence, industry initiatives, investment environment and support
Regional and global regulation landscape, standardization approaches for tackling challenges
Technology benchmarking for specific applications
An appendix is included, comprising lists with major participants in the study and most notable patents in the field.